Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial

1. Fizazi, K.
2. Tran, N.
3. Fein, L.
4. Matsubara, N.
5. Rodriguez-Antolin, A.
6. Alekseev, B.Y.
7. Özgüroğlu, M.
8. Ye, D.
9. Feyerabend, S.
10. Protheroe, A.
11. Sulur, G.
12. Luna, Y.
13. Li, S.
14. Mundle, S.
15. Chi, K.N.